Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,918 | -1,382 | -747 | -4,292 | -3,672 |
| Depreciation Amortization | N/A | N/A | N/A | 5 | 5 |
| Other Working Capital | 1,479 | 956 | 379 | 1,720 | 1,383 |
| Other Operating Activity | 239 | 242 | 228 | 1,869 | 1,789 |
| Operating Cash Flow | $-200 | $-184 | $-140 | $-697 | $-496 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 100 | 55 | N/A | N/A |
| Common Stock Issued | 201 | N/A | N/A | 755 | 476 |
| Other Financing Activity | -5 | 0 | 0 | -65 | -20 |
| Financing Cash Flow | $196 | $100 | $55 | $690 | $456 |
| Beginning Cash Position | 85 | 85 | 85 | 92 | 92 |
| End Cash Position | 81 | 1 | 0 | 85 | 52 |
| Net Cash Flow | $-4 | $-84 | $-85 | $-7 | $-40 |
| Free Cash Flow | |||||
| Operating Cash Flow | -200 | -184 | -140 | -697 | -496 |
| Free Cash Flow | -200 | -184 | -140 | -697 | -496 |